QR-Code

Management of bone metastases in patients with breast cancer: review of bone-modifying therapy, emerging new agents, and future directions

Bone metastases occur in 65-75% of patients with metastatic breast cancer. They are often associated with skeletal-related events (SREs), leading to significant morbidity and decline in quality of life (QoL). Treatment with bone-modifying agents is crucial to decrease the risk of SREs and improve Qo...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Gilbert Bader, Brianna Brown, Ashley Pariser Davenport, Margaret Gatti-Mays, Kai CC Johnson, Nerea Lopetegui-Lia, Dionisa Quiroga, Arya Mariam Roy, Sagar Sardesai, Daniel Stover, Robert Wesolowski
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2026-05-01
Schriftenreihe:Frontiers in Oncology
Schlagworte:
bisphosphonates
bone metastases
breast cancer
clodronate
denosumab
ibandronate
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fonc.2026.1823973/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge